Allianz Asset Management GmbH - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 298 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2024$5,452,321
-3.5%
65,905
-0.4%
0.01%
-11.1%
Q1 2024$5,648,805
+8.0%
66,184
+8.2%
0.01%0.0%
Q4 2023$5,231,246
-3.2%
61,177
+1.4%
0.01%0.0%
Q3 2023$5,405,974
+21.7%
60,348
+15.7%
0.01%
+12.5%
Q2 2023$4,440,562
-59.8%
52,156
-60.9%
0.01%
-60.0%
Q1 2023$11,040,836
+12.4%
133,424
+6.8%
0.02%
+5.3%
Q4 2022$9,824,565
+203.1%
124,915
+185.3%
0.02%
+171.4%
Q3 2022$3,241,000
-39.3%
43,778
-42.1%
0.01%
+75.0%
Q3 2021$5,341,000
+7.7%
75,654
+1.7%
0.00%0.0%
Q2 2021$4,957,000
-40.0%
74,3840.0%0.00%
-50.0%
Q1 2021$8,257,000
-55.1%
74,384
-51.9%
0.01%
-55.6%
Q4 2020$18,380,000
+28.7%
154,778
-5.4%
0.02%
+5.9%
Q3 2020$14,281,000
-19.8%
163,688
-17.6%
0.02%
-19.0%
Q2 2020$17,802,000
-3.4%
198,770
+7.5%
0.02%
-16.0%
Q1 2020$18,430,000
-16.4%
184,923
-3.6%
0.02%
+25.0%
Q4 2019$22,036,000
+3.1%
191,786
+13.2%
0.02%
-4.8%
Q3 2019$21,372,000
+16.0%
169,431
+10.7%
0.02%
+23.5%
Q2 2019$18,418,000
+58.5%
153,050
+15.2%
0.02%
+54.5%
Q1 2019$11,617,000
-7.5%
132,799
+5.8%
0.01%
-21.4%
Q4 2018$12,553,000
-16.4%
125,470
-4.2%
0.01%0.0%
Q3 2018$15,008,000
+25.6%
130,988
-1.7%
0.01%
+16.7%
Q2 2018$11,952,000
+43.8%
133,272
+17.3%
0.01%
+50.0%
Q1 2018$8,313,000113,6300.01%
Other shareholders
HAEMONETICS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Bridge City Capital, LLC 40,541$5,114,0002.20%
Lisanti Capital Growth, LLC 53,385$6,734,0002.20%
Nitorum Capital, L.P. 279,510$35,257,0002.05%
CROWN ADVISORS MANAGEMENT, INC. 20,000$2,523,0001.69%
Millrace Asset Group, Inc. 11,400$1,438,0001.69%
COOKSON PEIRCE & CO INC 145,884$18,402,0001.61%
Endurant Capital Management LP 32,594$4,111,0001.48%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 111,000$14,002,0001.38%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 110,065$13,884,0001.37%
EMERALD ADVISERS, LLC 203,640$25,687,0001.20%
View complete list of HAEMONETICS CORP shareholders